319 research outputs found
Ofloxacin pharmacokinetics in saliva
Objective: To study the pharmacokinetics of ofloxacin using salivary drug concentration when
administered alone or in combination with rifampicin (R), isoniazid (H) and pyrazinamide (Z) and
also to assess the saliva to plasma concentration ratio.
Material and Methods: Twelve healthy male volunteers were investigated on four different occasions
with an interval of at least one week between occasions. They were administered ofloxacin,
either alone or in combination with R, H and Z. A partially balanced incomplete block design was
adopted and the subjects were randomly allocated to each group. Salivary and plasma concentrations
of ofloxacin were measured at 1, 2, 3, 6 and 8 h after drug(s) administration using validated
methods.
Results: There were no significant differences between various pharmacokinetic parameters when
ofloxacin was administered alone or in combination with R, H and Z. The mean saliva to plasma
ratio of ofloxacin concentration was around 0.6. The bioavailability indices of ofloxacin in the
saliva and plasma were similar in all the groups.
Conclusion: Several pharmacokinetic parameters could be calculated using salivary concentrations
of ofloxacin. The determination of ofloxacin levels in saliva may be useful in therapeutic
drug monitoring and pharmacokinetic studies
Use of stable isotopes, organic and inorganic chemistry to identify pollution sources and weathering processes in two small tropical rivers in southwestern India
The two main objectives of this study were to assess pollution dynamic from organic and inorganic major ion chemistry and stable isotopes (δ15N and δ18O) and to determine the weathering processes using carbon isotopes in two tropical river basins, i.e. Nethravati and Swarna, along southwest coast of India. These short length river basins (around 100 km) are characterized by high annual rainfall, warm temperature, high runo" (~3300mm) draining Precambrian basement rocks composed of green-stones, granitic-gneiss, charnockite and meta sediments. Intense silicate weathering is induced by high runo" and warm temperature (Gurumurthy et al., 2012). In this study, stable isotopes (δ15N & δ18O)of organic molecules from sewage and agricultural effluents,and carbon isotopes (δ13C) of dissolved organic carbon (DOC) and dissolved inorganic carbon (DIC) were measured to trace agricultural and domestic pollution and to identify the sources of inorganic carbon and the nature of chemical weathering in these river basins. Carbon isotopes measured on DIC reveals sources of carbon into the river, such as carbonate/silicate weathering of rocks, mineralization of organic matter from C3/C4 plants, soil and atmospheric CO2. The nitrate and phosphate levels remain low, with values ranging from 5 to 9 μM, and 0 to 2 μM respectively. The δ13C DIC values range from =-9.03 +/- 0.99 for the Swarna basin to -8.08 +/-0.78 for the Nethravati basin. These values point to a mixing of carbonate and silicate weathering products with a dominance of C3 vegetation, prevalent in the Western Ghats. The DOC values for both river basins are very low and very close: 0.72 +/- 0.09 mg/L (Swarna river) and 0.62 +/-0.11 mg/L (Nethravati river). This indicates that the contributions of organic matter from the adjacent forests and the $ood plains are very low during the sampling period. The analysis of organic acids reveals low amount of Oxalate and Acetate, and trace of Malate and Tartaric acids. The dissolved and particulate organic carbon (DOC and POC) concentrations are very low in these two rivers. During the dry season, river discharge is mainly supplied by groundwater with generally low contents in dissolved and particulate fractions. Even if we observe low concentration, we measured higher DOC and POC in the Swarna river. These higher DOC concentrations are accompanied with lower SUVA value. This indicates that more labile DOC (less aromaticity) is exported within this basin during dry season. C/N values in POC also show that the organic carbon is “fresher” and is probably more autochtonous than in the Nethravati river. Indeed, C/N value are closer of an autochthonous production (C/N : 2-6) than allochthonous one (C/N: 8-20). These observations can be explained as the Svarna watershed land use is more agricultural than in Nethravati. Agricultural lands generally export signi%cant amount of nutrients to rivers and participate to enhance autochthonous productivity. Autochthonous organic carbon production is more labile and less aromatic
Dose related pharmacokinetics of ofloxacin in healthy volunteers
OBJECTIVE: To evaluate the pharmacokinetic profile of
ofloxacin in healthy volunteers after single oral doses of
600 and 800 mg.
DESIGN: Seven healthy volunteers were administered
600 and 800 mg of ofloxacin on two occasions with an
interval of one week. Paired samples of blood and saliva
were collected after 1, 2, 3, 6, 9, 12, 24, 32 and 48 hours
post-dose. Urine samples were collected over a period of
0–6, 6–12 and 12–24 hours. Concentrations of ofloxacin
in plasma, saliva and urine were assayed by high performance
liquid chromatography.
RESULTS: Increases of 22% in peak plasma concentration
(Cmax) and 40% in area under the concentrationtime
curve (AUC0–24) were observed with the 800 mg
dose. The other parameters, namely time to attain Cmax,
half-life, the apparent volume of distribution, plasma
and renal clearance and percentage of dose excreted in
urine over 24 hours were independent of doses. The
mean ratios of the concentration in saliva to the concentration
in plasma ranged from 0.4–0.6, and the correlation
coefficient was 0.94.
CONCLUSIONS: Dose proportionality was observed in
Cmax and AUC0–24 when 600 and 800 mg doses of ofloxacin
were given. Ofloxacin determined in saliva seems to
be suitable for therapeutic drug monitoring
Pregnancy associated plasma protein-A (PAPP-A) as an early marker for the diagnosis of acute coronary syndrome.
Aims and objectives
Pregnancy associated plasma protein-A (PAPP-A), a metalloproteinase plays a pivotal role in the pathogenesis of atherosclerosis. Recent studies have reported that elevated levels of PAPP-A, signal the onset of acute coronary syndrome (ACS). We, therefore, proposed to study the analytical competence of PAPP-A in patients admitted to the emergency department with chest pain and finally diagnosed as ACS.
Methods and results
Pregnancy associated plasma protein-A was measured using enzyme-linked immunosorbent assay (ELISA) in 485 patients admitted to emergency care unit, of which 89 patients were diagnosed as Non-cardiac chest pain (NCCP). Elevated levels of PAPP-A were observed in patients diagnosed as ACS on comparison with the controls. Receiver operator characteristic (ROC) curve analysis showed PAPP-A to be a good discriminator between ischaemic and non-ischaemic patients. The area under the curve was found to be 0.904, 95% CI (0.874–0.929) with 90% sensitivity and 85% specificity (P< 0.0001). The cut-off value from the ROC curve was 0.55 μg/mL above which PAPP-A was considered to be positive.
Conclusion
Pregnancy associated plasma protein-A seems to be a promising biomarker for identification and risk stratification for patients with ACS
Standardization of the method for estimation of ethambutol in pharmaceutical preparations and biological fluid
A simple column chromatographic method for determination of ethambutol (EMB) in pharmaceutical preparations
containing EMB in combination with other anti-TB drugs is presented. The method involved extraction of EMB into an
organic solvent. followed by basification and column chromatographic separation on Amberlite CG 50 (100-200 mesh) and
elution with suitable eluants and estimation at a wavelength of 270 nm. The assay was linear from 25 to 400 ÎĽg/ml. The
relative standard deviations of intra and inter day assays were lower than 5%. Ethambutol was recovered from human urine
quantitatively and stable for a period of atleast one week in urine stored at-20°C
Simple spectrofluorimetric and microbiological assay methods for the estimation of ofloxacin in biological fluids
Objective: To evolve simple methods for the assay of ofloxacin in biological fluids.
Methods: Simple methods for the estimation of ofloxacin in plasma, saliva and urine employing microbiological
assay using plate diffusion technique and by fluorimetric method based on the measurement
of native fluorescence emitted by ofloxacin, have been described.
Results: The recovery of ofloxacin from all the three biologial fluids was 93-98% and the sensitivity was
0.5 ÎĽg/ml on all 5 different occasions by both the methods. Anti-TB drugs viz., rifampicin, ethambutol,
isoniazid and pyrazinamide and also anti-leprosy drugs viz., dapsone and clofazimine at concentrations
of 10 and 20 ÎĽg/ml did not interfere with the estimation of ofloxacin by either method. Ofloxacin is stable
in biological fluids for a period of at least 8 days at -20°C.
Conclusion: Both the methods described are simple, involve very few steps and do not need either
costly chemicals or sophisticated equipments
Assay of ethambutol in pharmaceutical preparations
Ethambutol tablets of 200 and 400 mg denominations were assayed by the standard
non-aqueous titration method and a simpler calorimetric method. With the titrimetric method,
assay values, appreciably higher than the stated content (117% or more), were obtained with
the products of 4 companies, while all the values were within 6% of the stated content by
the calorimetric method. Rifampicin and pyrazinamide interfered with the estimation of
ethambutol by both methods: isoniazid, however, caused an overestimation with the titrimetric
method only
Bioavailability of rifampicin following concomitant administration of ethambutol or isoniazid or pyrazinamide or a combination of the three drugs
Background & Objectives: Poor bioavailability of rifampicin (R) in combination with other
anti-tuberculosis drugs such as isoniazid (H), pyrazinamide (Z), and ethambutol (E) is a subject of
much concern for the last few decades. This could be due to an interaction between R and other drugs.
An investigation was therefore undertaken to examine the bioavailability of R in the presence of H, Z
and E or a combination of the three drugs.
Methods: The study included eight healthy volunteers, each being investigated on four occasions at
weekly intervals once with R alone and with three of the four combinations on the three remaining
occasions. A partially balanced incomplete block design was employed and the allocation of R or the
drug combinations was random. Plasma concentrations of R at intervals upto 12 h were determined by
microbiological assay using Staphylococcus aureus as the test organism. The proportion (%) dose of R
as R plus desacetyl R (DR) in urine excreted over the periods 0-8 and 8-12 h was also determined.
Bioavailability was expressed as an index (BI) of area under time concentration curve (AUC) calculated
from the plasma concentrations or proportion of dose of R excreted as R plus DR in urine with the
combinations to that with R alone.
Results: The bioavailability indices based on AUC were 0.96 with RE, 0.76 with RH, 1.08 with RZ and
0.65 with REHZ. The indices based on urine estimations (0-8 h) were similar, the values being 0.94,
0.84, 0.94 and 0.75, respectively. A second investigation revealed that the decrease of bioavailability of
R with H was not due to the excipients present in H tablets.
Interpretation & conclusion: Isoniazid alone or in combination with E and Z reduces the bioavailability
of R. Urinary excretion data offer a simple and non invasive method for the assessment of bioavailability
of R
The Pharmacokinetics of ofloxacin, rifampicin, isoniazid and pyrazinmide when administered alone and in combination
The present study assesses the bioavailability of Ofloxacin (O)
following single oral administration of the drug along with Rifampicin
(R), or Isoniazid (H), or Pyrazinamide (Z) or a combination of three
drugs. Information on the pharmacokinetics of O in the presence of R,
H and Z based on the blood concentrations upto 8 hours, on the
proportions of the doses of the drugs and their metabolites excreted in
urine upto 8 hours and also the effect of O on the other antituberculosis
(TB) drugs in terms of absorption and interactions are
extensively studied. The bioavailability indices of these drugs are
assessed. The investigation was undertaken in a total of 12 male
healthy volunteers and each volunteer was investigated on four
different occasions at weekly intervals. A partially balanced incomplete
block design was employed and the allocation of O or the drug
combinations was at random. Plasma concentrations of O, R, H and Z
were determined. Urinary excretion of these drugs, together with their
primary metabolites was also determined. Various pharmacokinetic
parameters were calculated. The results have shown that the
bioavailability of O is not impaired when administered with other antituberculosis
drugs like R, H and Z and does not exercise any
therapeutic penalty. The bioavailability of other anti-TB drugs like R, H
and Z does not get affected when administered along with O. Human
bioavailability studies, in general, provide direct straightforward
information on the degree of absorption and biotransformation of
drugs. The results of the present study indicate that the
pharmacokinetic properties of O, R, H and Z as assessed after
individual and combined administration of these drugs do not get
affected or altered. Since there are no interactions among these drugs,
the use of 0 in the treatment of pulmonary tuberculosis is justified
A transgenic pig model expressing a CMV-ZsGreen1 reporter across an extensive array of tissues.
Since genetic engineering of pigs can benefit both biomedicine and agriculture, selecting a suitable gene promoter is critically important. The cytomegalovirus (CMV) promoter, which can robustly drive ubiquitous transgene expression, is commonly used at present, yet recent reports suggest tissue-specific activity in the pig. The objective of this study was to quantify ZsGreen1 protein (in lieu of CMV promoter activity) in tissues from pigs harboring a CMV-ZsGreen1 transgene with a single integration site. Tissue samples
- …